# Postpartum Family Planning

> **NCT03844633** · PHASE4 · TERMINATED · sponsor: **Ohio State University** · enrollment: 49 (actual)

## Conditions studied

- Delay in Time to Lactogenesis Stage II

## Interventions

- **DRUG:** Depo-Provera Injectable Product
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03844633
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-21
- **Primary completion:** 2021-05-26
- **Final completion:** 2022-04-18
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Because of insufficient enrollment, we closed the RCT and replaced it with an observational design
- **Last updated:** 2024-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03844633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03844633, "Postpartum Family Planning". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03844633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*